SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures)NQF 0081/PQRI 5 (Additional) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

NQF 0081/PQRI 5 (Additional) - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)

Measure: NQF 0081 (Additional Measurement)

Measure Title: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD

Measure Description: Percentage of patients aged 18 years and older with a diagnosis of heart failure and LVSD (LVEF < 40%) who were prescribed ACE inhibitor or ARB therapy.

*REQUIRED FOR MEANINGFUL USE (MU): Click here to view the Meaningful Use Criteria.

Quality Measure Documentation Workflow

1.  The patient must be 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period.

2.  Patients must have a diagnosis of Heart Failure (HF) and LVSD documented in the Summary Active Problems or the Assessment field of the encounter using one of the following ICD codes:

402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9

3.  Two documentation options:

(a) Documentation that an ACE inhibitor or ARB therapy was prescribed by entering the following SMARText code into the Summary Interventions or encounter Plan field using "PQRIhfACE": 4010F. *Note: Legacy CPT code 4009F will also count towards this measure.

OR

(b) Documentation that an ACE inhibitor or ARB therapy was prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

Micardis - d04364, Cozaar/Losartan - d03821, Diovan - d04113, Accuretic - d04509, Accupril - d00365, Altace - d00728, Captopril - d00006, Captozide - d03566, Lisinopril - d00732, Lotensin/Benzepril - d00730, Lotensin-HCT - d03265, Monopril/Fosinopril - d00242, Monopril-HCT - d04539, Zestoretic - d03266.

Note: Redownload PQRIhfACE

Note: Redownload PQRIhfACE

If the PQRIhfACE pick list you are using does not contain code 4010F, please redownload the pick list from the SOAPware Cloud Library.

To do this:

  1. Type "pqrihface" into the SOAPnote Plan field.
  2. With your cursor direclty behing the word, hit the Shift + F11 keys.
  3. Double-click on the item that has a shortcut code of PQRIhfACE and a downward facing green arrow. *Note: If you do not see this item, make sure the "Show Unused" box is checked.

Measure Calculation Details

Numerator Calculation:

The numerator for this measure is calculated based on the following:

1.  The number of patients in the denominator who have one of the following documented during the reporting period:

(a) The following SMARText CPT code documented in the Summary Interventions for or the encounter Plan field using "PQRIhfACE" to document that an ACE inhibitor or ARB therapy was prescribed:

  • 4010F
  • *Note: Legacy CPT code 4009F will also increase the numerator for this measure.

OR

(b) Documentation that an ACE inhibitor or ARB therapy was prescribed by entering one of the following medications into the encounter Medications or Summary Medications field:

  • Micardis: d04364
  • Cozaar/Losartan: d03821
  • Diovan: d0411
  • Accuretic: d04509
  • Accupril: d00365
  • Altace: d00728
  • Captopril: d00006
  • Captozide: d03566
  • Lisinopril: d00732
  • Lotensin/Benzepril: d00730
  • Lotensin-HCT: d03265
  • Monopril/Fosinopril: d00242
  • Monopril-HCT: d04539
  • Zestoretic: d03266

Denominator Calculation:

The denominator for this measurement is calculated based on the following:

1.  The number of patients who are 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period

2.  And have a diagnosis of Heart Failure in the Summary Active Problems field or encounter Assessment field documented using one of the following ICD9 codes:

  • 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 428.0, 428.1, 428.20, 428.21, 428.22, 428.23, 428.30, 428.31, 428.32, 428.33, 428.40, 428.41, 428.42, 428.43, 428.9

Report Clinical Quality Measures to CMS/Status

All of the items listed in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For information on how to export the numerator, denominator and percentage for each Clinical Quality Measure, click here.

For more information on reporting Clinical Quality Measures, click here.